U.S. Asks Endo to Pull Opana Painkiller From Market

The U.S. Food and Drug Administration is asking Endo Pharmaceuticals Inc. to remove its Opana ER from the market over concerns about the painkiller’s links to injection drug abuse, in what the agency called its first effort to remove an opioid pain drug from sale.

from WSJ.com: US Business http://ift.tt/2s1ppPJ
via IFTTT